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INTRODUCTION
A central nervous system (CNS) site of action generally requires that, following
entry into the systemic circulation, substances must interact with the blood-brain
barrier (BBB) en route to brain tissue targets. Many substances with CNS
activity, including drugs of abuse, cross the BBB by simple passive diffusion
(Oldendorf 1974; Levin 1980; Cornford et al. 1982). Accordingly, the BBB
plays an important role in regulating access of drugs of abuse to the brain.
Recent evidence suggests that some drugs of abuse may alter BBB
permeability characteristics. The permeability-altering activity of drugs
of abuse at the BBB has been reported in chronic amphetamine intoxication
(Rakic et al. 1989), acute ethanol exposure (Gulati et al. 1985), and opiate
treatment (Baba et al. 1988). Ethanol addiction also has been reported to
alter opiate interactions with the transport systems of the BBB (Banks and
Kastin 1989). On the basis of these reports, one might infer that interactions
of drugs of abuse with the BBB may have implications for the observed
pharmacological and toxicological manifestations of exposure to these
substances. These implications remain to be explored and confirmed.
Consequently, the development of a fundamental understanding of the
permeability and metabolic features of the BBB may contribute to a broader
knowledge of the activity of drugs of abuse In the CNS.
The complexity of the whole animal as an experimental model has certain
limitations when specific events at the cellular or molecular level are examined.
In vitro models (i.e., brain microvessel suspensions or cultured brain endothelial
cells) offer a promising alternative for the investigation of cellular- or molecular-
level characteristics of the BBB (Audus et al. 1990; Audus and Borchardt
1987). The purpose of this chapter is to describe studies of the transport
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and metabolism characteristics of the BBB that employ cultured brain
microvessel endothelial cells as in vitro BBB models. This chapter does not
describe isolated suspensions of brain microvessel endothelial cells as in vitro
models, since this subject has been reviewed by Betz and Goldstein (1984)
and more recently by Takakura and coworkers (1991 a). In addition, this
chapter does not describe how cultured brain microvessel endothelial cells
have been used to study the development and regulation of the BBB and
pathological changes in the BBB, since these topics are discussed in other
chapters in this monograph and have been reviewed previously by Takakura
and coworkers (1991 a).
ESTABUSHMENT AND CHARACTERIZATION OF CULTURED BRAIN
MICROVESSEL ENDOTHELIAL CELLS AS IN VITRO BBB MODELS
Since Panula and colleagues (1978) demonstrated that rat brain microvessel
endothelial cells could be maintained in tissue culture, various kinds of both
primary and passaged cultures of isolated brain microvessel endothelial cells
have been established from mouse, rat, bovine, human, canine, and porcine
brain (for a review, see Audus et al. 1990).
In general, either enzymatic or mechanical dispersal, or a combination of both
techniques, followed by either filtration or centrifugation steps are employed to
isolate a homogeneous population of brain microvessel endothelial cells from
the extremely heterogeneous population of cells found in brain tissues. For
example, isolation of a viable, homogeneous population of brain capillary
endothelial cells for establishment of a tissue culture system is accomplished
by a two-step enzymatic digestion with dispase and a dispase/collagenase
mixture of cerebral gray matter and successive centrifugation over dextran
and percoll gradients (Bowman et al. 1983; Audus and Borchardt 1986a,
1987). In the authors’ laboratories, primary cultures of bovine brain microvessel
endothelial cell monolayers have been shown to retain morphological and
biochemical properties typical of the BBB in vivo. These include tight junctions,
attenuated pinocytosis, lack of fenestra, and the presence of proteins (e.g., y-
glutamyl transpeptidase, alkaline phosphatase, angiotensin-converting enzyme,
factor VIII antigen) enriched in the endothelium of the BBB (Audus and
Borchardt 1986a, 1987).
Basically, two types of experimental systems have been employed for study of
transport phenomena using cultured brain microvessel endothelial cells: The
first is the uptake study, and the second involves a transcellular transport study.
The former system uses microvessel endothelial cell monolayers grown in
culture dishes (Scriba and Borchardt 1989a, 1989b). Uptake experiments can
be performed also using cerebral microvessel endothelial cells cultured on
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microcarriers (e.g., dextran beads) (Bottaro et al. 1986; Kempski et al. 1987).
These systems allow examination of the first step of the transport process,
that is, the uptake of the solutes into the brain capillary cells from the luminal
side. The most sophisticated in vitro system for transport studies consists of
cultured brain microvessel endothelial cell monolayers grown on microporous
membranes. Transport studies can then be conducted in side-by-side diffusion
cells or the cell-insert system (Audus et al. 1990). These systems afford an
opportunity to look at bidirectional transendothelial movement (transfer from
brain to blood and that from blood to brain) of solutes across the BBB in vitro
since, at least for primary cultures of bovine microvessel endothelial cells, the
cells are shown to be morphologically and functionally polarized in terms of ricin
recycling (Raub and Audus 1990), transferrin transport (Newton and Raub
1988), and angiotensin II (Ang II) responsiveness (Guillot and Audus 1990,
1991a). The purity of these monolayers is greater than 95 percent (Gurllot et
al. 1990). and the transelectrical resistance is 160±18  ohm/cm2 (T.J. Raub,
unpublished results).
Although bovine brain microvessel endothelial monolayers retain tight junctions,
the tight junctions are not identical to those observed in vivo with regard to
extent and complexity. This leads to higher leakiness in vitro than in vivo,
which is a disadvantage in the use of cultured endothelial cells alone to study
transcellular transport.
More impermeable monolayers of cultured brain microvessel endothelial cells
may be developed in the future by exploiting the regulatory role of astrocytes in
endothelial cell growth and development. It is widely accepted that the brain
microvessel endothelial cells in vivo form the structural and functronal bases
of the BBB; however, some of the BBB functions are known to be regulated
by astrocytes, which encircle the microvessel endothelial cells with their foot
processes In vivo. Similar regulatory effects of astrocytes on the permeability
properties of cultured endotheltal cells in vitro have been reported. For
example, Cancilla and DeBauIt (1983) demonstrated that contact with glial
cells (a rat line of neoplastic astrocytes designated as C6 glioma cells) or
exposure to glial-conditioned media enhances neutral amino acid uptake by
passaged mouse cerebral endothelial cells in culture. Conditioned media
prepared from astrocytes and C6 glioma cells have been shown to stimulate
glucose uptake in passaged mouse cerebral endothelial cells (Maxwell et al.
1989) and in primary cultures of bovine brain microvessel endothelial cells
(Takakura et al. 1991 b). Conditioned media from rat astrocytes or C6 glioma
cells also ,have been shown to decrease the permeability of various solutes
across monolayers of bovine brain microvessel endothelial cells grown on
microporous membranes (Trammel and Borchardt 1989; Raub et al. 1989).
Recently, Dehouck and colleagues (1990) observed decreases in permeability
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and increases in electrical resistance using an in vitro model system consisting
of passaged brain microvessel endothelial cells grown on one side of a filter and
astrocytes on the other side of the filter.
UPTAKE AND TRANSPORT STUDIES
Nutrients
Since glucose is an important source of energy for the brain, the mechanism
of glucose transport across the BBB has been particularly well studied in
vivo (Pardridge 1983). These studies support the concept that glucose is
transported through the cerebral microvessel endothelium mainly by the
mechanism of carrier-mediated facilitated diffusion. Glucose transport
characteristics also were studied in cultured brain microvessel endothellal
cells. For example, Vinters and coworkers (1985) demonstrated that the
properties of 3-O-methylglucose (3MG) and 2-deoxyglucose uptake in
established lines of cultured mouse cerebral microvessel endothelium are
similar to those observed in vivo. Recently, characteristics of both uptake and
transendothelial transport of 3MG were studied in primary cultures of bovine
brain microvessel endothelial cells (Takakura et al. 1991c). The uptake
characteristics of 3MG were shown to be identical to those observed in vivo
and in vitro using isolated capillaries. Transport rates from the luminal to
abluminal side and from the abluminal to luminal side, measured across the
brain microvessel endothelial cells grown onto polycarbonate membranes,
were nearly identical, suggesting symmetrical glucose transport across the
monolayer of endothellal cells.
The passage of amino acids across the BBB was found to be saturable and
stereospecific in vivo (Oldendorf 1971). Cancilla and DeBault (1983) showed
the presence of A- and L-systems for uptake of neutral amino acids in cultured
mouse cerebral endothelial cells. Using primary cultures of bovine brain
microvessel endothelial cell monolayers grown onto microporous membranes,
transport of a large neutral amino acid, leucine, was shown to be saturable,
bidirectional, competitive with other amino acids, and energy independent
(Audus and Borchardt 1986b). The kinetic parameters for leucine transport
appear to be in good agreement with true kinetic parameters of the in vivo
BBB. The transport of several amino acid drugs-including baclofen (van
Bree et al. 1988), a-methyldopa (Chastain and Borchardt 1989). and acivicin
(Chastain and Borchardt 1990)-by the amino acid carrier also has been
explored in this system.
Because of a limited capability for de novo synthesis of choline, an important
precursor to acetylcholine and phospholipid, the brain must depend on the
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blood for its supply of choline. Cornford and colleagues (1978) demonstrated
the saturability of brain uptake of choline after intracarotid injection in rats.
Recently, Estrada and associates (1990) studied choline uptake by bovine
cerebral capillary endothelial cells in culture, demonstrating that these cells
were able to incorporate choline by a carrier-mediated mechanism. The
choline uptake was temperature dependent and was inhibited by choline
analogs but was not affected by ouabain or dinitrophenol. Transendothelial
transport of choline in cultured bovine brain microvessel endothelial cells
has been characterized (Trammel and Borchardt 1987); it has been shown
that the transport is saturable and is insensitive to ouabain and sodium azide,
suggesting a facilitated diffusion mechanism.
Since the brain is one of the most active tissues for carrying out nucleotide
and nucleic acid synthesis, the transport of nucleosides and purine bases
across the BBB has been of interest. By employing the intracarotid injection
technique in rats, Cornford and Oldendorf (1975) demonstrated the presence
of two independent carrier systems for nucleic precursors: a nucleoside carrier
and a purine base carrier. Beck and coworkers (1983) have described a
carrier-mediated uptake of adenosine into mouse cerebral capillary endothelial
cells in tissue culture. Characterization of the nucleoside uptake (e.g.,
adenosine, thymidine) into monolayers of cultured bovine brain endothelial
cells also was studied, and the results suggested the presence of a carrier-
mediated uptake of adenosine and thymidine (Shah and Borchardt 1989).
Adenosine uptake is primarily via the carrier-mediated pathway, whereas
thymidine enters by both a carrier-mediated and a passive pathway. Both
nucleosides are extensively metabolized (e.g., phosphorylated) in the cultured
bovine endothelial cells.
Peptides and Proteins
Although the physiological role of insulin in the regulation of brain functions
remains to be elucidated, van Houten and Posner (1979) revealed that blood
vessels throughout the CNS of the rat bind plasma insulin rapidly and with
considerable specificity in vivo. The binding and receptor-mediated endocytosis
of insulin and insulin-like growth factor I (IGF-I) also were studied using cultured
bovine brain microvessel endothelial cells (Keller and Borchardt 1987; Keller et
al. 1988). Rosenfeld and colleagues (1987) showed the similarity between the
characteristics of the specific receptors for IGF-I and insulin-like growth factor II
in the cultured bovine brain microvessel endothelial cells and in isolated rat
brain microvessels.
Using monoclonal antibodies to the transferrin receptors, Jefferies and
coworkers (1984) first reported that rat and human brain capillary endothelia
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have receptors for transferrin, an iron-transport protein in the circulation.
Newton and Raub (1988) characterized the transferrin receptor in primary
cultures of brain capillary endothelial cells, indicating saturable binding and
internalization. They also demonstrated the transcytosis and the polarized
efflux of transferrin using brain microvessel endothelial cells grown onto
polycarbonate filters; these findings are in good agreement with the in vivo
observations of Fishman and coworkers (1987) and Banks and coworkers
(1988).
Atrial natriuretic factor (ANF), which is a 28-amino acid peptide produced by
cardiac myocytes and released in response to increases in atrial pressure,
expresses its natriuretic, diuretic, and hypotensive effects by acting on renal
and vascular tissues. A specific receptor for ANF also was identified using
primary cultures of bovine brain capillary endothelial cells (Smith et al. 1988).
The binding of ANF was specific, saturable, and reversible. ANF also was
shown to be rapidly internalized by a temperature-dependent process, A
specific receptor for brain natriuretic peptide (BNP), which was found in the
brain and has similarity to ANF in its structure and biological activities (Sudoh et
al. 1988), was identified recently in primary cultures of bovine brain microvessel
endothelial cells (M. Fukuta, M. Nonomura, Y. Takakura, and R.T. Borchardt,
unpublished results). These studies suggested that ANF and BNP share the
same receptor in bovine brain microvessel endothelium.
Speth and Harik (1985) reported that Ang II binds to microvessels isolated from
dog brain in a specific, saturable, and reversible manner and with high affinity.
It was suggested that specific Ang II receptor-binding sites are present in brain
microvessels and that these receptors may have an important role in regulating
the microcirculation of the brain. Work in the authors’ laboratories indicates that
bovine brain microvessel endothelial cell monolayers retain a high-affinity Ang II
binding site that can be competed for by Ang II peptides (Guillot and Audus
1991b).
Recently, the transport of leu-enkephalin across the BBB by a carrier-mediated
mechanism has been demonstrated in vivo (Zlokovic et al. 1987). In addition,
Thompson and Audus (1989) showed that leu-enkephalin transfer across
monolayers of brain microvessel endothelial cells occurs at a relatively high
rate, which is consistent with a facilitated diffusion mechanism.
Vasopressin transport across the BBB has been examined with primary
cultures of brain microvessel endothelial monolayers (Reardon and Audus
1989). Results suggest the existence of facilitated transport of the peptide from
the abluminal to the luminal side of the monolayers. This finding is consistent
with the in vivo characterization of a vasopressin BBB transport system (Banks
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et al. 1987). Van Bree and colleagues (1989) also have studied transport of
vasopressin using an in vitro system and suggested that no carrier mediation is
involved over a higher concentration range. Confirmatory studies are required
to clarify the transport mechanism in detail.
Raeissi and Audus (1989) characterized the BBB permeability to delta sleep-
inducing peptide (DSIP) in cultured microvessel endothelial cells. The results
support in vivo observations indicating that intact DSIP crosses the BBB by
simple transmembrane diffusion (Banks and Kastin 1987). Recently, Zlokovic
and coworkers (1989) presented evidence in support of a facilitative BBB carrier
for DSIP in vivo. Further work is ongoing concerning the solution structure of
DSIP, which may help to explain its ability to readily penetrate the BBB (Audus
and Manning 1990).
Native albumin, which is an acidic protein in plasma, is considered to pass
through the BBB very slowly (Pardridge et al. 1985). However, increased
BBB uptake and transport recently has been reported when it is chemically
modified. Kumagai and colleagues (1987) demonstrated the enhanced binding
and adsorptive-mediated endocytosis of cationized albumin by isolated bovine
brain capillaries. The binding was saturable and inhibited by other polycations
(e.g., protamine, protamine sulfate, and polylysine). Similar results have
been reported for other types of polycationic proteins, including cationized
immunoglobulin G (Triguero et al. 1989) and histone (Pardridge et al. 1989).
Smith and Borchardt (1989) studied the binding, uptake, and transcellular
transport of bovine serum albumin (BSA), cationized BSA (cBSA), and
glycosylated BSA (gBSA) in cultured bovine brain microvessel endothelial cells.
This study demonstrated that cBSA and gBSA bind to the cells specifically and
are transported by an adsorptive-phase endocytotic mechanism. The use of
cationized albumin in directed delivery of peptides through the BBB was
examined by coupling ß-endorphin to cationized albumin via a disulfide linkage
(Kumagai et al. 1987).
Drugs
In contrast to water-soluble nutrients and peptides, which are transported
by specific carrier- or receptor-mediated systems as mentioned above, most
water-soluble solutes, including drugs, pass through the BBB by a passive
diffusion mechanism. From in vivo studies, it has been well established that
the permeability of these molecules across the BBB depends directly on their
lipophilicity and inversely on their molecular size (Oldendorf 1974; Levin 1980;
Cornford et al. 1982). Rim and coworkers (1986) and Shah and coworkers
(1989) established a positive correlation between lipid solubility of a drug and
its permeability across bovine brain microvessel endothelial monolayers grown
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onto microporous membranes. As mentioned earlier in this chapter,
brain microvessel endothelial monolayers are leakier than the BBB in vivo.
Therefore, this leakiness in the monolayers must be corrected for by using
impermeant marker molecules (e.g., sucrose, fluorescein, inulin, and dextran)
when drug transport studies are conducted (Shah et al. 1989).
IN VITRO STUDIES ON BBB METABOLISM
Several different enzyme systems have been established in primary cultures
of bovine brain microvessel endothelial cell monolayers. Both biochemical and
histochemical techniques have been used to follow the expression of marker
and catecholamine-metabolizing enzymes associated with these monolayers.
For instance, enzyme systems considered markers for the BBB, glutamyl
transpeptidase and alkaline phosphatase, and for the endothelium, angiotensin-
converting enzyme, are retained in the monolayers (Baranczyk-Kuzma et al.
1986). In addition, the brain microvessel endothelial cell monolayers retain the
ability to degrade catecholamines through expression of monoamine oxidases A
and B, catechol O-methyltransferase, and phenol sulfotransferase (Baranczyk-
Kuzma et al. 1986, 1989a; Scriba and Borchardt 1989a. 1989b). Using
monolayers of bovine brain microvessel endothelial cells, the metabolism of
catecholamine esters (Scriba and Borchardt l989a) and of 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP) has been studied (Scriba and Borchardt
1989b).
The lysosomal compartment of endothelia is an important component of the
transcytosis of macromolecules (Simionescu 1979). Current interest by the
pharmaceutical industry in the delivery of therapeutic biotechnology products
to the CNS (Audus et al. 1990) suggests a need for considering the activity of
the lysosomal compartment of the BBB. However, little work has focused on
lysosomal or acid hydrolase compartments within the BBB in vivo. By both
quantitative and qualitative measures, bovine brain microvessel endothelial
cells possess a lysosomal compartment that expresses typical acid hydrolases,
acid phosphatase, ß-galactose, and sulfatases (Baranczyk-Kuzma et al. 1989b).
Peptidase activity has not yet been examined in the lysosomal fraction;
however, aminopeptidase activity is characteristic of membrane and cytosolic
fractions of the cells (Baranczyk-Kuzma and Audus 1987). Corresponding
quantitative studies in in vivo enzyme systems and compartments have not
been performed and may not be feasible. Therefore, the in vitro model may be
a reasonable system in which to initiate further studies on the contributions of
the lysosomal compartment to the fate of endocytosed peptides and proteins at
the BBB (Baranczyk-Kuzma et al. 1989b).
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CONCLUSIONS
The development of in vitro BBB models consisting of cultured brain
microvessel endothelial cells has made possible the study of BBB transport
and metabolism phenomena at the cellular level. Basic characteristics of
BBB transport and metabolism of endogenous and exogenous solutes and
their biochemical, pharmacological, ontogenic, and pathological regulation
mechanisms have been investigated. This information has led not only to a
better understanding of BBB transport but also to the construction of strategies
for improving drug delivery to the CNS for diagnosis and therapeutics. To
elucidate the complexity of BBB transport, in vivo studies are always necessary
at some point; however, in vitro systems can be useful complements to in vivo
systems. The tissue culture systems seem to be especially important in the
clarification of cellular, biochemical, and molecular features of BBB transport.
Appropriate systems should be selected or combined, depending on the
purpose of the investigation.
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